1887

Chapter 13 : Human Granulocytic Anaplasmosis (Ehrlichiosis)

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Human Granulocytic Anaplasmosis (Ehrlichiosis), Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816490/9781555812386_Chap13-1.gif /docserver/preview/fulltext/10.1128/9781555816490/9781555812386_Chap13-2.gif

Abstract:

Human granulocytic anaplasmosis (HGA) is a recently recognized acute febrile illness caused by . Like Lyme disease, its causative agent is transmitted by ixodid ticks, and small mammals likely serve as reservoir hosts. The pathogen is noteworthy in its preferential targeting and intracellular infection of neutrophils. Its range is still being defined, but it has been documented in geographic areas in North America and Europe similar to those of Lyme disease, and coinfections with can occur. The illness is characterized by high fever, myalgias, arthralgias, and headache, often with accompanying thrombocytopenia and leukopenia. Intracellular colonies of bacteria (morulae) may be seen in peripheral blood neutrophils but are often absent early in the course of infection. If the disease is suspected and appropriate therapy (usually doxycycline) is promptly initiated, the outcome is excellent. However, delayed diagnosis and treatment may result in organ failure and even death. This chapter describes the etiologic agent, biology, life cycle, transmission, and zoonotic hosts of . It also presents epidemiology, clinical manifestations, laboratory and pathologic findings, differential diagnosis, diagnostic testing, treatment, and prevention of infection.

Citation: Goodman J. 2005. Human Granulocytic Anaplasmosis (Ehrlichiosis), p 218-238. In Goodman J, Dennis D, Sonenshine D, Tick-Borne Diseases of Humans. ASM Press, Washington, DC. doi: 10.1128/9781555816490.ch13

Key Concept Ranking

Major Histocompatibility Complex Class I
0.4222886
0.4222886
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1
Figure 1

Life cycle of in infected human (HL60) cells. (A) Binding to the cell surface; (B) internalization; (C) replication within the endosome with failure of fusion with lysosomal granules; (D) cell filled with multiple infected endosomes, near lysis ( ).

Citation: Goodman J. 2005. Human Granulocytic Anaplasmosis (Ehrlichiosis), p 218-238. In Goodman J, Dennis D, Sonenshine D, Tick-Borne Diseases of Humans. ASM Press, Washington, DC. doi: 10.1128/9781555816490.ch13
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

Distribution of cases of HGA reported to the CDC in 2001 ( ).

Citation: Goodman J. 2005. Human Granulocytic Anaplasmosis (Ehrlichiosis), p 218-238. In Goodman J, Dennis D, Sonenshine D, Tick-Borne Diseases of Humans. ASM Press, Washington, DC. doi: 10.1128/9781555816490.ch13
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 3
Figure 3

PCR amplification of 16S rRNA sequence from the blood of the first patients from whom the organism was isolated ( ). The pretreatment detection of pathogen DNA is seen, as well as the reduction in signal soon after treatment. WB, sample of whole blood; HL60, same sample(s) following cultivation in HL60 cells. The 16S amplicon was a positive control standard with the described numbers of DNA copies used in the PCR. Tick cell line IDE infected with an equine isolate (likely conspecific with ) is another positive control. The assay is sensitive to ~10 organisms or fewer. (Reprinted with permission from the .)

Citation: Goodman J. 2005. Human Granulocytic Anaplasmosis (Ehrlichiosis), p 218-238. In Goodman J, Dennis D, Sonenshine D, Tick-Borne Diseases of Humans. ASM Press, Washington, DC. doi: 10.1128/9781555816490.ch13
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555816490.chap13
1. Adachi, J. A.,, E. M. Grimm,, P. Johnson,, M. Uthman,, B. Kaplan,, and R. M. Rakita. 1997. Human granulocytic ehrlichiosis in a renal transplant patient: case report and review of the literature. Transplantation 64: 1139 1142.
2. Aguero-Rosenfeld, M. E. 2003. Laboratory aspects of tickborne diseases: Lyme, human granulocytic ehrlichiosis and babesiosis. Mt. Sinai J. Med. 70: 197 206.
3. Aguero-Rosenfeld, M. E.,, H. W. Horowitz,, G. P. Wormser,, D. F. McKenna,, J. Nowakowski,, J. Munoz,, and J. S. Dumler. 1996. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann. Intern. Med. 125: 904 908.
4. Akkoyunlu, M.,, and E. Fikrig. 2000. Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia. Infect. Immun. 68: 1827 1833.
5. Akkoyunlu, M.,, S. E. Malawista,, J. Anguita,, and E. Fikrig. 2001. Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis. Infect. Immun. 69: 5577 5588.
6. Arens, M. Q.,, A. M. Liddell,, G. Buening,, M. Gaudreault- Keener,, J. W. Sumner,, J. A. Comer,, R. S. Buller,, and G. A. Storch. 2003. Detection of Ehrlichia spp. in the blood of wild white-tailed deer in Missouri by PCR assay and serologic analysis. J. Clin. Microbiol. 41: 1263 1265.
7. Arnez, M.,, T. Luznik-Bufon,, T. Avsic-Zupanc,, E. Ruzic- Sabljic,, M. Petrovec,, S. Lotric-Furlan,, and F. Strle. 2003. Causes of febrile illnesses after a tick bite in Slovenian children. Pediatr. Infect. Dis. J. 22: 1078 1083.
8. Bakken, J. S.,, M. E. Aguero-Rosenfeld,, R. L. Tilden,, G. P. Wormser,, H. W. Horowitz,, J. T. Raffalli,, M. Baluch,, D. Riddell,, J. J. Walls,, and J. S. Dumler. 2001. Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis. Clin. Infect. Dis. 32: 862 870.
9. Bakken, J. S.,, and J. S. Dumler. 2000. Human granulocytic ehrlichiosis. Clin. Infect. Dis. 31: 554 560.
10. Bakken, J. S.,, J. S. Dumler,, S. M. Chen,, M. R. Eckman,, L. L. Van Etta,, and D. H. Walker. 1994. Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA 272: 212 218.
11. Bakken, J. S.,, S. A. Erlemeyer,, R. J. Kanoff,, T. C. Silvestrini,, D. D. Goodwin,, and J. S. Dumler. 1998. Demyelinating polyneuropathy associated with human granulocytic ehrlichiosis. Clin. Infect. Dis. 27: 1323 1324.
12. Bakken, J. S.,, I. Haller,, D. Riddell,, J. J. Walls,, and J. S. Dumler. 2002. The serological response of patients infected with the agent of human granulocytic ehrlichiosis. Clin. Infect. Dis. 34: 22 27.
13. Bakken, J. S.,, J. Krueth,, C. Wilson-Nordskog,, R. L. Tilden,, K. Asanovich,, and J. S. Dumler. 1996. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 275: 199 205.
14. Banerjee, R.,, J. Anguita,, and E. Fikrig. 2000. Granulocytic ehrlichiosis in mice deficient in phagocyte oxidase or inducible nitric oxide synthase. Infect. Immun. 68: 4361 4362.
15. Banerjee, R.,, J. Anguita,, D. Roos,, and E. Fikrig. 2000. Cutting edge: infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by down-regulating gp91phox. J. Immunol. 164: 3946 3949.
16. Behl, R.,, M. B. Klein,, L. Dandelet,, R. R. Bach,, J. L. Goodman,, and N. S. Key. 2000. Induction of tissue factor procoagulant activity in myelomonocytic cells inoculated by the agent of human granulocytic ehrlichiosis. Thromb. Haemost. 83: 114 118.
17. Belongia, E. A.,, K. D. Reed,, P. D. Mitchell,, P. H. Chyou,, N. Mueller-Rizner,, M. F. Finkel,, and M. E. Schriefer. 1999. Clinical and epidemiological features of early Lyme disease and human granulocytic ehrlichiosis in Wisconsin. Clin. Infect. Dis. 29: 1472 1477.
18. Belongia, E. A.,, K. D. Reed,, P. D. Mitchell,, C. P. Kolbert,, D. H. Persing,, J. S. Gill,, and J. J. Kazmierczak. 1997. Prevalence of granulocytic Ehrlichia infection among white-tailed deer in Wisconsin. J. Clin. Microbiol. 35: 1465 1468.
19. Belongia, E. A.,, K. D. Reed,, P. D. Mitchell,, N. Mueller- Rizner,, M. Vandermause,, M. F. Finkel,, and J. J. Kazmierczak. 2001. Tickborne infections as a cause of nonspecific febrile illness in Wisconsin. Clin. Infect. Dis. 32: 1434 1439.
20. Bjoersdorff, A.,, J. Berglund,, B. E. Kristiansen,, C. Soderstrom,, and I. Eliasson. 1999. Varying clinical picture and course of human granulocytic ehrlichiosis. Twelve Scandinavian cases of the new tick-borne zoonosis are presented. Lakartidningen 96: 4200 4204. (In Swedish.)
21. Bjoersdorff, A.,, B. Wittesjo,, J. Berglun,, R. F. Massung,, and I. Eliasson. 2002. Human granulocytic ehrlichiosis as a common cause of tick-associated fever in southeast Sweden: report from a prospective clinical study. Scand. J. Infect. Dis. 34: 187 191.
22. Blanco, J. R.,, and J. A. Oteo. 2002. Human granulocytic ehrlichiosis in Europe. Clin. Microbiol. Infect. 8: 763 772.
23. Borjesson, D. L.,, S. I. Simon,, E. Hodzic,, C. M. Ballantyne,, and S. W. Barthold. 2002. Kinetics of CD11b/CD18 up-regulation during infection with the agent of human granulocytic ehrlichiosis in mice. Lab. Investig. 82: 303 311.
24. Brandsma, A. R.,, S. E. Little,, J. M. Lockhart,, W. R. Davidson,, D. E. Stallknecht,, and J. E. Dawson. 1999. Novel Ehrlichia organism (Rickettsiales: Ehrlichieae) in white-tailed deer associated with lone star tick (Acari: Ixodidae) parasitism. J. Med. Entomol. 36: 190 194.
25. Brouqui, P.,, and J. S. Dumler. 2000. Serologic evidence of human monocytic and granulocytic ehrlichiosis in Israel. Emerg. Infect. Dis. 6: 314 315.
26. Brouqui, P.,, and D. Raoult. 1992. In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis. Antimicrob. Agents Chemother. 36: 2799 2803.
27. Brouqui, P.,, E. Salvo,, J. S. Dumler,, and D. Raoult. 2001. Diagnosis of granulocytic ehrlichiosis in humans by immunofluorescence assay. Clin. Diagn. Lab. Immunol. 8: 199 202.
28. Brown, W. C.,, V. Shkap,, D. Zhu,, T. C. McGuire,, W. Tuo,, T. F. McElwain,, and G. H. Palmer. 1998. CD4 + T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge. Infect. Immun. 66:5406- 5413.
29. Buitrago, M. I.,, J. W. Ijdo,, P. Rinaudo,, H. Simon,, J. Copel,, J. Gadbaw,, R. Heimer,, E. Fikrig,, and F. J. Bia. 1998. Human granulocytic ehrlichiosis during pregnancy treated successfully with rifampin. Clin. Infect. Dis. 27: 213 215.
30. Bunnell, J. E.,, L. A. Magnarelli,, and J. S. Dumler. 1999. Infection of laboratory mice with the human granulocytic ehrlichiosis agent does not induce antibodies to diagnostically significant Borrelia burgdorferi antigens. J. Clin. Microbiol. 37: 2077 2079.
31. Bunnell, J. E.,, E. R. Trigiani,, S. R. Srinivas,, and J. S. Dumler. 1999. Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent-infected cells in a murine model system. J. Infect. Dis. 180: 546 550.
32. Burkot, T. R.,, G. O. Maupin,, B. S. Schneider,, C. Denatale,, C. M. Happ,, J. S. Rutherford,, and N. S. Zeidner. 2001. Use of a sentinel host system to study the questing behavior of Ixodes spinipalpis and its role in the transmission of Borrelia bissettii, human granulocytic ehrlichiosis, and Babesia microti. Am. J. Trop. Med. Hyg. 65: 293 299.
33. Carlyon, J. A.,, M. Akkoyunlu,, L. Xia,, T. Yago,, T. Wang,, R. D. Cummings,, R. P. McEver,, and E. Fikrig. 2003. Murine neutrophils require α1,3-fucosylation but not PSGL-1 for productive infection with Anaplasma phagocytophilum. Blood 102: 3387 3395.
34. Carlyon, J. A.,, W. T. Chan,, J. Galan,, D. Roos,, and E. Fikrig. 2002. Repression of rac2 mRNA expression by Anaplasma phagocytophila is essential to the inhibition of superoxide production and bacterial proliferation. J. Immunol. 169: 7009 7018.
35. Carlyon, J. A.,, D. A. Latif,, M. Pypaert,, P. Lacy,, and E. Fikrig. 2004. Anaplasma phagocytophilum utilizes multiple host evasion mechanisms to thwart NADPH oxidase-mediated killing during neutrophil infection. Infect. Immun. 72: 4772 4783.
36. Carlyon, J. A. Centers for Disease Control and Prevention. 1995. Human granulocytic ehrlichiosis—New York, 1995. JAMA 274: 867.
37. Carlyon, J. A. Centers for Disease Control and Prevention. 2004. Summary of notifiable diseases—United States 2002. Morb. Mortal. Wkly. Rep. 51: 1 84.
38. Chang, Y. F.,, V. Novosel,, C. F. Chang,, J. B. Kim,, S. J. Shin,, and D. H. Lein. 1998. Detection of human granulocytic ehrlichiosis agent and Borrelia burgdorferi in ticks by polymerase chain reaction. J. Vet. Diagn. Investig. 10: 56 59.
39. Chaput, E. K.,, J. I. Meek,, and R. Heimer. 2002. Spatial analysis of human granulocytic ehrlichiosis near Lyme, Connecticut. Emerg. Infect. Dis. 8: 943 948.
40. Chen, S. M.,, J. S. Dumler,, J. S. Bakken,, and D. H. Walker. 1994. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J. Clin. Microbiol. 32: 589 595.
41. Choi, K. S.,, D. G. Scorpio,, and J. S. Dumler. 2004. Anaplasma phagocytophilum ligation to toll-like receptor (TLR) 2, but not to TLR4, activates macrophages for nuclear factor-kappa B nuclear translocation. J. Infect. Dis. 189: 1921 1925.
42. Christova, I. S.,, and J. S. Dumler. 1999. Human granulocytic ehrlichiosis in Bulgaria. Am. J. Trop. Med. Hyg. 60: 58 61.
43. Cinco, M.,, D. Padovan,, R. Murgia,, M. Heldtander,, and E. O. Engvall. 1998. Detection of HGE agent-like Ehrlichia in Ixodes ricinus ticks in northern Italy by PCR. Wien. Klin. Wochenschr. 110: 898 900.
44. Daniel, S. A.,, K. Manika,, M. Arvanitidou,, E. Diza,, N. Symeonidis,, and A. Antoniadis. 2002. Serologic evidence of human granulocytic ehrlichiosis, Greece. Emerg. Infect. Dis. 8: 643 644.
45. Daniels, T. J.,, G. R. Battaly,, D. Liveris,, R. C. Falco,, and I. Schwartz. 2002. Avian reservoirs of the agent of human granulocytic ehrlichiosis? Emerg. Infect. Dis. 8: 1524 1525.
46. des Vignes, F.,, and D. Fish. 1997. Transmission of the agent of human granulocytic ehrlichiosis by host-seeking Ixodus scapularis (Acari: Ixodidae) in southern New York state. J. Med. Entomol. 34: 379 382.
47. des Vignes, F.,, J. Piesman,, R. Heffernan,, T. L. Schulze,, K. C. Stafford III,, and D. Fish. 2001. Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs. J. Infect. Dis. 183: 773 778.
48. Dumler, J. S.,, and J. S. Bakken. 1996. Human granulocytic ehrlichiosis in Wisconsin and Minnesota: a frequent infection with the potential for persistence. J. Infect. Dis. 173: 1027 1030.
49. Dumler, J. S.,, A. F. Barbet,, C. P. Bekker,, G. A. Dasch,, G. H. Palmer,, S. C. Ray,, Y. Rikihisa,, and F. R. Rurangirwa. 2001. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and ‘HGE agent’ as subjective synonyms of Ehrlichia phagocytophila. Int. J. Syst. Evol. Microbiol. 51: 2145 2165.
50. Dumler, J. S.,, E. R. Trigiani,, J. S. Bakken,, M. E. Aguero- Rosenfeld,, and G. P. Wormser. 2000. Serum cytokine responses during acute human granulocytic ehrlichiosis. Clin. Diagn. Lab. Immunol. 7: 6 8.
51. Edelman, D. C.,, and J. S. Dumler. 1996. Evaluation of an improved PCR diagnostic assay for human granulocytic ehrlichiosis. Mol. Diagn. 1: 41 49.
52. Edelson, B. T.,, and E. R. Unanue. 2001. Intracellular antibody neutralizes Listeria growth. Immunity 14: 503 512.
53. Fingerle, V.,, J. L. Goodman,, R. C. Johnson,, T. J. Kurtti,, U. G. Munderloh,, and B. Wilske. 1997. Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high-risk groups. J. Clin. Microbiol. 35: 3244 3247.
54. Fingerle, V.,, U. G. Munderloh,, G. Liegl,, and B. Wilske. 1999. Coexistence of ehrlichiae of the phagocytophila group with Borrelia burgdorferi in Ixodes ricinus from southern Germany. Med. Microbiol. Immunol. (Berlin) 188: 145 149.
55. Gardner, S. L.,, R. C. Holman,, J. W. Krebs,, R. Berkelman,, and J. E. Childs. 2003. National surveillance for the human ehrlichioses in the United States, 1997-2001, and proposed methods for evaluation of data quality. Ann. N. Y. Acad. Sci. 990: 80 89.
56. Goodman, J. L.,, and Herron, M. J. Unpublished data.
57. Goodman, J. L.,, C. Nelson,, B. Vitale,, J. E. Madigan,, J. S. Dumler,, T. J. Kurtti,, and U. G. Munderloh. 1996. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N. Engl. J. Med. 334: 209 215.
58. Goodman, J. L.,, C. M. Nelson,, M. B. Klein,, S. F. Hayes,, and B. W. Weston. 1999. Leukocyte infection by the granulocytic ehrlichiosis agent is linked to expression of a selectin ligand. J. Clin. Investig. 103: 407 412.
59. Greig, B.,, K. M. Asanovich,, P. J. Armstrong,, and J. S. Dumler. 1996. Geographic, clinical, serologic, and molecular evidence of granulocytic ehrlichiosis, a likely zoonotic disease, in Minnesota and Wisconsin dogs. J. Clin. Microbiol. 34: 44 48.
60. Gribble, D. H. 1969. Equine ehrlichiosis. J. Am. Vet. Med. Assoc. 155: 462 469.
61. Hayes, S. F.,, C. M. Nelson,, and J. L. Goodman. The life cycle of A. phagocytophilum in human cells. Unpublished data.
62. Herron, M. J.,, and J. L. Goodman. 2001. Proceedings, 16 th American Society for Rickettsiology Annual Meeting.
63. Herron, M. J.,, C. M. Nelson,, J. Larson,, K. R. Snapp,, G. S. Kansas,, and J. L. Goodman. 2000. Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1. Science 288: 1653 1656.
64. Reference deleted.
65. Hodzic, E.,, D. Fish,, C. M. Maretzki,, A. M. De Silva,, S. Feng,, and S. W. Barthold. 1998. Acquisition and transmission of the agent of human granulocytic ehrlichiosis by Ixodes scapularis ticks. J. Clin. Microbiol. 36: 3574 3578.
66. Horowitz, H. W.,, M. Aguero-Rosenfeld,, J. S. Dumler,, D. F. McKenna,, T. C. Hsieh,, J. Wu,, I. Schwartz,, and G. P. Wormser. 1998. Reinfection with the agent of human granulocytic ehrlichiosis. Ann. Intern. Med. 129: 461 463.
67. Horowitz, H. W.,, M. E. Aguero-Rosenfeld,, D. F. McKenna,, D. Holmgren,, T. C. Hsieh,, S. A. Varde,, S. J. Dumler,, J. M. Wu,, I. Schwartz,, Y. Rikihisa,, and G. P. Wormser. 1998. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin. Infect. Dis. 27: 1314 1317.
68. Horowitz, H. W.,, T. C. Hsieh,, M. E. Aguero-Rosenfeld,, F. Kalantarpour,, I. Chowdhury,, G. P. Wormser,, and J. M. Wu. 2001. Antimicrobial susceptibility of Ehrlichia phagocytophila. Antimicrob. Agents Chemother. 45: 786 788.
69. Horowitz, H. W.,, E. Kilchevsky,, S. Haber,, M. Aguero- Rosenfeld,, R. Kranwinkel,, E. K. James,, S. J. Wong,, F. Chu,, D. Liveris,, and I. Schwartz. 1998. Perinatal transmission of the agent of human granulocytic ehrlichiosis. N. Engl. J. Med. 339: 375 378.
70. Horowitz, H. W.,, S. J. Marks,, M. Weintraub,, and J. S. Dumler. 1996. Brachial plexopathy associated with human granulocytic ehrlichiosis. Neurology 46: 1026 1029.
71. Ijdo, J. W.,, C. Wu,, L. A. Magnarelli,, and E. Fikrig. 1999. Serodiagnosis of human granulocytic ehrlichiosis by a recombinant HGE-44-based enzyme-linked immunosorbent assay. J. Clin. Microbiol. 37: 3540 3544.
72. Jahangir, A.,, C. Kolbert,, W. Edwards,, P. Mitchell,, J. S. Dumler,, and D. H. Persing. 1998. Fatal pancarditis associated with human granulocytic ehrlichiosis in a 44-year-old man. Clin. Infect. Dis. 27: 1424 1427.
73. Jauron, S. D.,, C. M. Nelson,, V. Fingerle,, M. D. Ravyn,, J. L. Goodman,, R. C. Johnson,, R. Lobentanzer,, B. Wilske,, and U. G. Munderloh. 2001. Host cell-specific expression of a p44 epitope by the human granulocytic ehrlichiosis agent. J. Infect. Dis. 184: 1445 1450.
74. Kalantarpour, F.,, I. Chowdhury,, G. P. Wormser,, and M. E. Aguero-Rosenfeld. 2000. Survival of the human granulocytic ehrlichiosis agent under refrigeration conditions. J. Clin. Microbiol. 38: 2398 2399.
75. Katavolos, P.,, P. M. Armstrong,, J. E. Dawson,, and S. R. Telford III. 1998. Duration of tick attachment required for transmission of granulocytic ehrlichiosis. J. Infect. Dis. 177: 1422 1425.
76. Kim, H. Y.,, and Y. Rikihisa. 2000. Expression of interleukin- 1β, tumor necrosis factor alpha, and interleukin-6 in human peripheral blood leukocytes exposed to human granulocytic ehrlichiosis agent or recombinant major surface protein P44. Infect. Immun. 68: 3394 3402.
77. Klein, M. B.,, S. F. Hayes,, and J. L. Goodman. 1998. Monocytic differentiation inhibits infection and granulocytic differentiation potentiates infection by the agent of human granulocytic ehrlichiosis. Infect. Immun. 66: 3410 3415.
78. Klein, M. B.,, S. Hu,, C. C. Chao,, and J. L. Goodman. 2000. The agent of human granulocytic ehrlichiosis induces the production of myelosuppressing chemokines without induction of proinflammatory cytokines. J. Infect. Dis. 182: 200 205.
79. Klein, M. B.,, J. S. Miller,, C. M. Nelson,, and J. L. Goodman. 1997. Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis. J. Infect. Dis. 176: 1405 1409.
80. Klein, M. B.,, C. M. Nelson,, and J. L. Goodman. 1997. Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins. Antimicrob. Agents Chemother. 41: 76 79.
81. Kocan, K. M.,, J. delaFuente,, A. A. Guglielmone,, and R. D. Melendez. 2003. Antigens and alternatives for control of Anaplasma marginale infection in cattle. Clin. Microbiol. Rev. 16: 698 712.
82. Kocan, K. M.,, T. Halbur,, E. F. Blouin,, V. Onet,, J. de la Fuente,, J. C. Garcia-Garcia,, and J. T. Saliki. 2001. Immunization of cattle with Anaplasma marginale derived from tick cell culture. Vet. Parasitol. 102: 151 161.
83. Kramer, V. L.,, M. P. Randolph,, L. T. Hui,, W. E. Irwin,, A. G. Gutierrez,, and D. J. Vugia. 1999. Detection of the agents of human ehrlichioses in ixodid ticks from California. Am. J. Trop. Med. Hyg. 60: 62 65.
84. Krause, P. J.,, C. L. Corrow,, and J. S. Bakken. 2003. Successful treatment of human granulocytic ehrlichiosis in children using rifampin. Pediatrics 112: e252 e253.
85. Layfield, D.,, and P. Guilfoile. 2002. The prevalence of Borrelia burgdorfieri (Spirochaetales: spirochaetaceae) and the agent of human granulocytic ehrlichiosis (Rickettsiaceae: Ehrlichieae) in Ixodes scapularis (Acari: Ixodidae) collected during 1998 and 1999 from Minnesota. J. Med. Entomol. 39: 218 220.
86. Lee, H. C.,, J. Han,, R. K. Purr,, and J. L. Goodman. 2004. Anaplasma phagocytophilum inhibits human neutrophil apoptosis through multiple molecular pathways: genomic studies. FDA 2004 Science Forum.
86. Lepidi, H.,, J. E. Bunnell,, M. E. Martin,, J. E. Madigan,, S. Stuen,, and J. S. Dumler. 2000. Comparative pathology, and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections. Am. J. Trop. Med. Hyg. 62: 29 37.
87. Levin, M. L.,, F. des Vignes,, and D. Fish. 1999. Disparity in the natural cycles of Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis. Emerg. Infect. Dis. 5: 204 208.
88. Levin, M. L.,, W. L. Nicholson,, R. F. Massung,, J. W. Sumner,, and D. Fish. 2002. Comparison of the reservoir competence of medium-sized mammals and Peromyscus leucopus for Anaplasma phagocytophilum in Connecticut . Vector Borne Zoonotic Dis. 2: 125 136.
89. Little, S. E.,, D. E. Stallknecht,, J. M. Lockhart,, J. E. Dawson,, and W. R. Davidson. 1998. Natural coinfection of a whitetailed deer ( Odocoileus virginianus) population with three Ehrlichia spp. J. Parasitol. 84: 897 901.
90. Liz, J. S.,, J. W. Sumner,, K. Pfister,, and M. Brossard. 2002. PCR detection and serological evidence of granulocytic ehrlichial infection in roe deer ( Capreolus capreolus) and chamois ( Rupicapra rupicapra). J. Clin. Microbiol. 40: 892 897.
91. Lodes, M. J.,, R. Mohamath,, L. D. Reynolds,, P. McNeill,, C. P. Kolbert,, E. S. Bruinsma,, D. R. Benson,, E. Hofmeister,, S. G. Reed,, R. L. Houghton,, and D. H. Persing. 2001. Serodiagnosis of human granulocytic ehrlichiosis by using novel combinations of immunoreactive recombinant proteins. J. Clin. Microbiol. 39: 2466 2476.
92. Lotric-Furlan, S.,, M. Petrovec,, T. Avsic-Zupanc,, and F. Strle. 2003. Comparison of patients fulfilling criteria for confirmed and probable human granulocytic ehrlichiosis. Ann. N. Y. Acad. Sci. 990: 344 345.
93. Lotric-Furlan, S.,, M. Petrovec,, T. Avsic-Zupanc,, and F. Strle. 2003. Human granulocytic ehrlichiosis in Slovenia. Ann. N. Y. Acad. Sci. 990: 279 284.
94. Lotric-Furlan, S.,, M. Petrovec,, T. A. Zupanc,, W. L. Nicholson,, J. W. Sumner,, J. E. Childs,, and F. Strle. 1998. Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for four patients from Slovenia. Clin. Infect. Dis. 27: 424 428.
95. Madigan, J. E.,, and D. Gribble. 1987. Equine ehrlichiosis in northern California: 49 cases (1968-1981). J. Am. Vet. Med. Assoc. 190: 445 448.
96. Magnarelli, L.,, J. Ijdo,, C. Wu,, and E. Fikrig. 2001. Recombinant protein-44-based class-specific enzyme-linked immunosorbent assays for serologic diagnosis of human granulocytic ehrlichiosis. Eur. J. Clin. Microbiol. Infect. Dis. 20: 482 485.
97. Magnarelli, L. A.,, J. W. Ijdo,, S. J. Padula,, R. A. Flavell,, and E. Fikrig. 2000. Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens. J. Clin. Microbiol. 38: 1735 1739.
98. Magnarelli, L. A.,, K. C. Stafford III,, T. N. Mather,, M. T. Yeh,, K. D. Horn,, and J. S. Dumler. 1995. Hemocytic rickettsialike organisms in ticks: serologic reactivity with antisera to ehrlichiae and detection of DNA of agent of human granulocytic ehrlichiosis by PCR. J. Clin. Microbiol. 33: 2710 2714.
99. Magnarelli, L. A.,, K. C. Stafford III,, T. N. Mather,, M. T. Yeh,, K. D. Horn,, and J. S. Dumler. 1995. Hemocytic rickettsia- like organisms in ticks: serologic reactivity with antisera to ehrlichiae and detection of DNA of agent of human granulocytic ehrlichiosis by PCR. J. Clin. Microbiol. 33: 2710 2714.
100. Martin, M. E.,, K. Caspersen,, and J. S. Dumler. 2001. Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis. Am. J. Pathol. 158: 1881 1888.
101. Massung, R. F.,, K. Slater,, J. H. Owens,, W. L. Nicholson,, T. N. Mather,, V. B. Solberg,, and J. G. Olson. 1998. Nested PCR assay for detection of granulocytic ehrlichiae. J. Clin. Microbiol. 36: 1090 1095.
102. Massung, R. F.,, and K. G. Slater. 2003. Comparison of PCR assays for detection of the agent of human granulocytic ehrlichiosis, Anaplasma phagocytophilum. J. Clin. Microbiol. 41: 717 722.
103. Maurin, M.,, J. S. Bakken,, and J. S. Dumler. 2003. Antibiotic susceptibilities of Anaplasma ( Ehrlichia) phagocytophilum strains from various geographic areas in the United States. Antimicrob. Agents Chemother. 47: 413 415.
104. McGarey, D. J.,, A. F. Barbet,, G. H. Palmer,, T. C. McGuire,, and D. R. Allred. 1994. Putative adhesins of Anaplasma marginale: major surface polypeptides 1a and 1b. Infect. Immun. 62: 4594 4601.
105. McQuiston, J. H.,, C. D. Paddock,, R. C. Holman,, and J. E. Childs. 1999. The human ehrlichioses in the United States. Emerg. Infect. Dis. 5: 635 642.
106. Morozova, O. V.,, A. K. Dobrotvorsky,, N. N. Livanova,, S. E. Tkachev,, V. N. Bakhvalova,, A. B. Beklemishev,, and F. C. Cabello. 2002. PCR detection of Borrelia burgdorferi sensu lato, tick-borne encephalitis virus, and the human granulocytic ehrlichiosis agent in Ixodes persulcatus ticks from western Siberia, Russia. J. Clin. Microbiol. 40: 3802 3804.
107. Mott, J.,, R. E. Barnewall,, and Y. Rikihisa. 1999. Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells. Infect. Immun. 67: 1368 1378.
108. Munderloh, U. G.,, S. D. Jauron,, V. Fingerle,, L. Leitritz,, S. F. Hayes,, J. M. Hautman,, C. M. Nelson,, B. W. Huberty,, T. J. Kurtti,, G. G. Ahlstrand,, B. Greig,, M. A. Mellencamp,, and J. L. Goodman. 1999. Invasion and intracellular development of the human granulocytic ehrlichiosis agent in tick cell culture. J. Clin. Microbiol. 37: 2518 2524.
109. Munderloh, U. G.,, M. J. Lynch,, M. J. Herron,, A. T. Palmer,, T. J. Kurtti,, R. D. Nelson,, and J. L. Goodman. 2004. Infection of endothelial cells with Anaplasma marginale and A. phagocytophilum. Vet. Microbiol. 101: 53 64.
110. Nadelman, R. B.,, J. Nowakowski,, D. Fish,, R. C. Falco,, K. Freeman,, D. McKenna,, P. Welch,, R. Marcus,, M. E. Aguero-Rosenfeld,, D. T. Dennis,, and G. P. Wormser. 2001. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N. Engl. J. Med. 345: 79 84.
111. Nicholson, W. L.,, M. B. Castro,, V. L. Kramer,, J. W. Sumner,, and J. E. Childs. 1999. Dusky-footed wood rats ( Neotoma fuscipes) as reservoirs of granulocytic ehrlichiae ( Rickettsiales: Ehrlichieae) in northern California. J. Clin. Microbiol. 37: 3323 3327.
112. Ogden, N. H.,, Z. Woldehiwet,, and C. A. Hart. 1998. Granulocytic ehrlichiosis: an emerging or rediscovered tick-borne disease? J. Med. Microbiol. 47: 475 482.
113. Oteo, J. A.,, H. Gil,, M. Barral,, A. Perez,, S. Jimenez,, J. R. Blanco,, V. MartinezdeArtola,, V. A. Garcia-Perez,, and R. A. Juste. 2001. Presence of granulocytic ehrlichia in ticks and serological evidence of human infection in La Rioja, Spain. Epidemiol. Infect. 127: 353 358.
114. Pancholi, P.,, C. P. Kolbert,, P. D. Mitchell,, K. D. Reed,, Jr., J. S. Dumler,, J. S. Bakken,, S. R. Telford III,, and D. H. Persing. 1995. Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J. Infect. Dis. 172: 1007 1012.
115. Prukk, T.,, K. Ainsalu,, E. Laja,, and A. Aigro. 2003. Human granulocytic ehrlichiosis in Estonia. Emerg. Infect. Dis. 9: 1499 1500.
116. Rabinstein, A.,, V. Tikhomirov,, A. Kaluta,, N. Gelfmann,, P. Iannini,, and L. Edwards. 2000. Recurrent and prolonged fever in asplenic patients with human granulocytic ehrlichiosis. QJM 93: 198 201.
117. Ramsey, A. H.,, E. A. Belongia,, C. M. Gale,, and J. P. Davis. 2002. Outcomes of treated human granulocytic ehrlichiosis cases. Emerg. Infect. Dis. 8: 398 401.
118. Ravyn, M. D.,, J. L. Goodman,, C. B. Kodner,, D. K. Westad,, L. A. Coleman,, S. M. Engstrom,, C. M. Nelson,, and R. C. Johnson. 1998. Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates. J. Clin. Microbiol. 36: 1480 1488.
119. Reubel, G. H.,, R. B. Kimsey,, J. E. Barlough,, and J. E. Madigan. 1998. Experimental transmission of Ehrlichia equi to horses through naturally infected ticks ( Ixodes pacificus) from northern California. J. Clin. Microbiol. 36: 2131 2134.
120. Richter, P. J., Jr.,, R. B. Kimsey,, J. E. Madigan,, J. E. Barlough,, J. S. Dumler,, and D. L. Brooks. 1996. Ixodes pacificus (Acari: Ixodidae) as a vector of Ehrlichia equi (Rickettsiales: Ehrlichieae). J. Med. Entomol. 33: 1 5.
121. Ruscio, M.,, and M. Cinco. 2003. Human granulocytic ehrlichiosis in Italy: first report on two confirmed cases. Ann. N. Y. Acad. Sci. 990: 350 352.
122. Saint, A. A.,, N. M. Blackwell,, L. R. Hall,, A. Hoerauf,, N. W. Brattig,, L. Volkmann,, M. J. Taylor,, L. Ford,, A. G. Hise,, J. H. Lass,, E. Diaconu,, and E. Pearlman. 2002. The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science 295: 1892 1895.
123. Schwartz, I.,, D. Fish,, and T. J. Daniels. 1997. Prevalence of the rickettsial agent of human granulocytic ehrlichiosis in ticks from a hyperendemic focus of Lyme disease. N. Engl. J. Med. 337: 49 50.
124. Skarphedinsson, S.,, P. Sogaard,, and C. Pedersen. 2001. Seroprevalence of human granulocytic ehrlichiosis in high-risk groups in Denmark. Scand. J. Infect. Dis. 33: 206 210.
125. Strle, F. 2004. Human granulocytic ehrlichiosis in Europe. Int. J. Med. Microbiol(Suppl. 37). 293: 27 35.
126. Sumner, J. W.,, W. L. Nicholson,, and R. F. Massung. 1997. PCR amplification and comparison of nucleotide sequences from the groESL heat shock operon of Ehrlichia species. J. Clin. Microbiol. 35: 2087 2092.
127. Sun, W.,, J. W. Ijdo,, S. R. IIITelford,, E. Hodzic,, Y. Zhang,, S. W. Barthold,, and E. Fikrig. 1997. Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J. Clin. Investig. 100: 3014 3018.
128. Sun, W., Task Force on Consensus Approach for Ehrlichiosis (CAFE). 2000. Diagnosing human ehrlichioses: current status and recommendations. ASM News 66: 277 280.
129. Taylor, G. A.,, C. G. Feng,, and A. Sher. 2004. p47 GTPases: regulators of immunity to intracellular pathogens. Nat. Rev. Immunol. 4: 100 109.
130. Telford, S. R.,, III ,J. E. Dawson,, P. Katavolos,, C. K. Warner,, C. P. Kolbert,, and D. H. Persing. 1996. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc. Natl. Acad. Sci. USA 93: 6209 6214.
131. Trofe, J.,, K. S. Reddy,, R. J. Stratta,, S. D. Flax,, K. T. Somerville,, R. R. Alloway,, M. F. Egidi,, M. H. Shokouh- Amiri,, and A. O. Gaber. 2001. Human granulocytic ehrlichiosis in pancreas transplant recipients. Transpl. Infect. Dis. 3: 34 39.
132. Unver, A.,, S. Felek,, C. D. Paddock,, N. Zhi,, H. W. Horowitz,, G. P. Wormser,, L. C. Cullman,, and Y. Rikihisa. 2001. Western blot analysis of sera reactive to human monocytic ehrlichiosis and human granulocytic ehrlichiosis agents. J. Clin. Microbiol. 39: 3982 3986.
133. Vannorsdall, M. D.,, S. Thomas,, R. P. Smith,, R. Zimmerman,, R. Christman,, and J. P. Vella. 2002. Human granulocytic ehrlichiosis in a renal allograft recipient: review of the clinical spectrum of disease in solid organ transplant patients. Transpl. Infect. Dis. 4: 97 101.
134. Varde, S.,, J. Beckley,, and I. Schwartz. 1998. Prevalence of tick-borne pathogens in Ixodes scapularis in a rural New Jersey county. Emerg. Infect. Dis. 4: 97 99.
135. Von Loewenich, F. D.,, D. G. Scorpio,, U. Reischl,, J. S. Dumler,, and C. Bogdan. 2004. Frontline: control of Anaplasma phagocytophilum, an obligate intracellular pathogen, in the absence of inducible nitric oxide synthase, phagocyte NADPH oxidase, tumor necrosis factor, Toll-like receptor (TLR) 2 and TLR4, or the TLR adaptor molecule MyD88. Eur. J. Immunol. 34: 1789 1797.
136. Walls, J. J.,, P. Caturegli,, J. S. Bakken,, K. M. Asanovich,, and J. S. Dumler. 2000. Improved sensitivity of PCR for diagnosis of human granulocytic ehrlichiosis using epank1 genes of Ehrlichia phagocytophila-group ehrlichiae. J. Clin. Microbiol. 38: 354 356.
137. Walls, J. J.,, B. Greig,, D. F. Neitzel,, and J. S. Dumler. 1997. Natural infection of small mammal species in Minnesota with the agent of human granulocytic ehrlichiosis. J. Clin. Microbiol. 35: 853 855.
138. Webster, P.,, J. W. Ijdo,, L. M. Chicoine,, and E. Fikrig. 1998. The agent of human granulocytic ehrlichiosis resides in an endosomal compartment. J. Clin. Investig. 101: 1932 1941.
139. Whist, S. K.,, A. K. Storset,, G. M. Johansen,, and H. J. Larsen. 2003. Modulation of leukocyte populations and immune responses in sheep experimentally infected with Anaplasma (formerly Ehrlichia) phagocytophilum. Vet. Immunol. Immunopathol. 94: 163 175.
140. Woldehiwet, Z. 1983. Tick-borne fever: a review. Vet. Res. Commun. 6: 163 175.
141. Wormser, G. P.,, H. W. Horowitz,, J. Nowakowski,, D. McKenna,, J. S. Dumler,, S. Varde,, I. Schwartz,, C. Carbonaro,, and M. Aguero-Rosenfeld. 1997. Positive Lyme disease serology in patients with clinical and laboratory evidence of human granulocytic ehrlichiosis. Am. J. Clin. Pathol. 107: 142 147.
142. Wormser, G. P.,, R. B. Nadelman,, R. J. Dattwyler,, D. T. Dennis,, E. D. Shapiro,, A. C. Steere,, T. J. Rush,, D. W. Rahn,, P. K. Coyle,, D. H. Persing,, D. Fish,, and B. J. Luft. 2000. Practice guidelines for the treatment of Lyme disease. Guideline from the Infectious Diseases Society of America. Clin. Infect. Dis. 31( Suppl. 1): 1 14.
143. Yago, T.,, A. Leppanen,, J. A. Carlyon,, M. Akkoyunlu,, S. Karmakar,, E. Fikrig,, R. D. Cummings,, and R. P. McEver. 2003. Structurally distinct requirements for binding of P-selectin glycoprotein ligand-1 and sialyl Lewis x to Anaplasma phagocytophilum and P-selectin. J. Biol. Chem. 278: 37987 37997.
144. Yoshiie, K.,, H. Y. Kim,, J. Mott,, and Y. Rikihisa. 2000. Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect. Immun. 68: 1125 1133.
145. Zeidner, N. S.,, T. R. Burkot,, R. Massung,, W. L. Nicholson,, M. C. Dolan,, J. S. Rutherford,, B. J. Biggerstaff,, and G. O. Maupin. 2000. Transmission of the agent of human granulocytic ehrlichiosis by Ixodes spinipalpis ticks: evidence of an enzootic cycle of dual infection with Borrelia burgdorferi in northern Colorado. J. Infect. Dis. 182: 616 619.
146. Zhi, N.,, N. Ohashi,, Y. Rikihisa,, H. W. Horowitz,, G. P. Wormser,, and K. Hechemy. 1998. Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis. J. Clin. Microbiol. 36: 1666 1673.

Tables

Generic image for table
Table 1

History, signs, and symptoms of HGA infection

Citation: Goodman J. 2005. Human Granulocytic Anaplasmosis (Ehrlichiosis), p 218-238. In Goodman J, Dennis D, Sonenshine D, Tick-Borne Diseases of Humans. ASM Press, Washington, DC. doi: 10.1128/9781555816490.ch13
Generic image for table
Table 2

Reported complications of HGA

Citation: Goodman J. 2005. Human Granulocytic Anaplasmosis (Ehrlichiosis), p 218-238. In Goodman J, Dennis D, Sonenshine D, Tick-Borne Diseases of Humans. ASM Press, Washington, DC. doi: 10.1128/9781555816490.ch13
Generic image for table
Table 3

Laboratory findings in HGA

Citation: Goodman J. 2005. Human Granulocytic Anaplasmosis (Ehrlichiosis), p 218-238. In Goodman J, Dennis D, Sonenshine D, Tick-Borne Diseases of Humans. ASM Press, Washington, DC. doi: 10.1128/9781555816490.ch13
Generic image for table
Table 4

Currently available HGA-specific diagnostic laboratory tests

Citation: Goodman J. 2005. Human Granulocytic Anaplasmosis (Ehrlichiosis), p 218-238. In Goodman J, Dennis D, Sonenshine D, Tick-Borne Diseases of Humans. ASM Press, Washington, DC. doi: 10.1128/9781555816490.ch13
Generic image for table
Table 5

Treatment of infection

Citation: Goodman J. 2005. Human Granulocytic Anaplasmosis (Ehrlichiosis), p 218-238. In Goodman J, Dennis D, Sonenshine D, Tick-Borne Diseases of Humans. ASM Press, Washington, DC. doi: 10.1128/9781555816490.ch13

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error